These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11681781)

  • 1. Spironolactone in left-sided heart failure: how does it fit in?
    Margo KL; Luttermoser G; Shaughnessy AF
    Am Fam Physician; 2001 Oct; 64(8):1393-8. PubMed ID: 11681781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-aldosterone therapy in severe heart failure].
    van Guldener C; Donker AJ
    Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of efficacy of low-dose spironolactone as adjunct treatment to conventional congestive heart failure treatment in dogs.
    Schuller S; Van Israël N; Vanbelle S; Clercx C; McEntee K
    J Vet Pharmacol Ther; 2011 Aug; 34(4):322-31. PubMed ID: 20950346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of spironolactone in a specialized heart failure clinic.
    Sligl W; McAlister FA; Ezekowitz J; Armstrong PW
    Am J Cardiol; 2004 Aug; 94(4):443-7. PubMed ID: 15325926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spironolactone for heart failure.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].
    Opasich C
    Ital Heart J Suppl; 2000 Mar; 1(3):425-6. PubMed ID: 10815276
    [No Abstract]   [Full Text] [Related]  

  • 8. [The process of drug development. The "case" of spironolactone].
    De Feo S; Opasich C; Volpi A; Tavazzi L
    Ital Heart J Suppl; 2002 Feb; 3(2):178-86. PubMed ID: 11926024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An old drug provides surprising benefits for heart-failure patients.
    Harv Heart Lett; 1999 Dec; 10(4):5-7. PubMed ID: 10564892
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J; Fraccarollo D
    Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spironolactone use in patients with heart failure.
    Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL
    J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing readmissions for congestive heart failure.
    Hoyt RE; Bowling LS
    Am Fam Physician; 2001 Apr; 63(8):1593-8. PubMed ID: 11327436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-benefit analysis of spironolactone use in the treatment of chronic heart failure].
    Alvarez JS; Vílchez FG
    Rev Esp Cardiol; 2001 Feb; 54(2):175-80. PubMed ID: 11181306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
    Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
    J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's old is new again. Spironolactone and heart failure.
    Lock M; Chun R
    Can Fam Physician; 1999 Nov; 45():2621-2. PubMed ID: 10587769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of heart failure treatment.
    Guyatt GH; Devereaux PJ
    Mt Sinai J Med; 2004 Jan; 71(1):47-54. PubMed ID: 14770250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of systolic heart failure: emphasis on mortality outcomes.
    Barbour MM; Zuwallack A
    Med Health R I; 2001 Feb; 84(2):55-8. PubMed ID: 11272661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA; Wendt C; Saborowski F
    Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.